Category: Translation & Commercialisation
Measurements and rewards influence behaviour. They not only influence what is performed, but also what is not. Key performance indicators are often used to measure the performance of employees; they prioritise activities and drive behaviour. The measures, rewards and potential of future grant successes that funders of research and their employers put into the research […]VIEW POST
Australia’s innovation efficiency is a wicked problem needing a solution. The ability for Australia to capitalise on its research efforts has consistently ranked well below expectations. One of the key opportunities for philanthropy is to innovate and test solutions that can be scaled to assist in solving wicked problems such as this and contribute towards […]VIEW POST
Bridging the Valley-of-Death to Create a Path to Successes, a Case for Publically Funded Drug Discovery.
Written by Associate Professor Bernard Flynn The Opportunity: The pharmaceutical sector is one of the most profitable industries in the world. The top 10 selling drugs all have annual sales in excess of US$6 bil pa. In the last 20 yrs the sector has been transformed, with many larger Pharma companies preferring to build […]VIEW POST
I started writing this post to provoke a conversation and scratch the surface on an important issue. There are many differing points of view and most are valid, and less valid at the same time depending on the lens you are looking through. Measuring impact from research requires a more sophisticated or complex conversation than […]VIEW POST
Written by Jenny Pyke Jenny is the R&D Program Advisor and Accreditation Manager with the National Association of Testing Authorities, Australia (NATA) There are ongoing discussions regarding the lack of reproducibility of research. This concern, expressed globally, has been fuelled by stakeholders’ failed attempts to reproduce key research outcomes and the retraction of some research papers, […]VIEW POST
Join a conversation with philanthropists, researchers, industry and government. Delivering impact from medical research.
In order to harness the benefits from medical research it is important to bring all key stakeholders together, including philanthropy, industry, government and academia. NFMRI’s conference uniquely provides this opportunity, creating an interactive forum to discuss opportunities, issues and ideas. We encourage delegates to submit questions in advance and contribute to the conversation. The […]VIEW POST
The ‘halo effect’ can be both a positive and negative for funders of research. How does it affect you?
A challenge for funders of research is that it often requires more than research to achieve their ultimate goals. Restricting funding to research is often set out in the terms of; a bequest, a donation, a grant, the constitution and may be a requirement for the funder to maintain charitable status. The outcome funders wish […]VIEW POST
Author: AusBiotech Innovation in biotechnology is a foundation stone of the future, providing solutions to human and animal disease, climate change, fuel alternatives and food security, as well as improving our quality of life. Australia is a global hub for biotechnology researchers, companies, investors and partners, which is strengthened by innovation-focussed policies and a not-to-be […]VIEW POST
Written by Dr Geoff Garrett AO FTSE, Chief Scientist of Queensland. SCIENCE VISION Winston Churchill: “The further backward you can look, the further forward you can see”. Steve Jobs: “You can’t connect the dots looking forward; you can only connect them looking backwards”. The Human Genome Project, completed in 2003, took 13 years and cost $2.7 billion. […]VIEW POST
Could this be a reality? We all know that not all good ideas gain traction and become reality. This is true for inventors, for business, for things around the home and for medical research. Discoveries and good ideas that are never disclosed and disappear without a trace may later be rediscovered and lead to future […]VIEW POST